POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE

POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE was reported 3206 times

POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, ASCORBIC ACID, SODIUM ASCORBATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANAL ECZEMA 2 0.1176
1 ANTACID THERAPY 15 0.1154
2 SLEEP DISORDER THERAPY 19 0.0960
3 CONGENITAL HIATUS HERNIA 19 0.0833
4 MALIGNANT MELANOMA STAGE 0 15 0.0718
5 ANALGESIC THERAPY 19 0.0592
6 DRUG THERAPY 18 0.0531
7 ANTICOAGULANT THERAPY 15 0.0528
8 VAGINAL FLATULENCE 15 0.0495
9 MUCOSAL EXCORIATION 2 0.0465
10 AMMONIA 2 0.0351
11 PHLEBITIS DEEP 2 0.0270
12 APPENDICOLITH 10 0.0258
13 BLOOD ANTIDIURETIC HORMONE INCREASED 2 0.0215
14 HYPONATRAEMIC ENCEPHALOPATHY 4 0.0198
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 16 0.0173
16 PNEUMOTHORAX TRAUMATIC 3 0.0124
17 WATER INTOXICATION 6 0.0119
18 BACTEROIDES INFECTION 3 0.0115
19 CROSS SENSITIVITY REACTION 11 0.0113
20 PRODUCT TASTE ABNORMAL 141 0.0104
21 POSTOPERATIVE DELIRIUM 2 0.0101
22 VOMITING PROJECTILE 29 0.0100
23 HYPERPHOSPHATAEMIA 21 0.0098
24 OESOPHAGEAL RUPTURE 8 0.0096
25 FEMALE GENITAL TRACT FISTULA 16 0.0094
26 RECTAL PERFORATION 5 0.0093
27 MUSCLE OEDEMA 2 0.0093
28 GASTRIC MUCOSA ERYTHEMA 3 0.0091
29 ANTICIPATORY ANXIETY 2 0.0074
30 PATIENT DISSATISFACTION WITH TREATMENT 14 0.0073
31 MALLORY-WEISS SYNDROME 9 0.0071
32 NEPHRITIC SYNDROME 2 0.0065
33 CHRONIC SINUSITIS 24 0.0064
34 BACTERIAL TRANSLOCATION 2 0.0063
35 ELECTROLYTE DEPLETION 3 0.0061
36 BREATH SOUNDS ABNORMAL 30 0.0061
37 PROCTITIS 17 0.0061
38 MENIERE'S DISEASE 2 0.0058
39 RADICULOPATHY 15 0.0057
40 EXPULSION OF MEDICATION 3 0.0057
41 LYMPHOID TISSUE HYPERPLASIA 2 0.0056
42 DISCOLOURED VOMIT 5 0.0052
43 POVERTY OF SPEECH 2 0.0051
44 PLEURITIC PAIN 14 0.0051
45 PNEUMONIA VIRAL 16 0.0050
46 TOTAL LUNG CAPACITY DECREASED 8 0.0050
47 RESPIRATORY SYMPTOM 14 0.0049
48 BONE NEOPLASM MALIGNANT 2 0.0048
49 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 23 0.0045
50 INTESTINAL DILATATION 6 0.0045
51 HYPERPARATHYROIDISM SECONDARY 11 0.0044
52 DIVERTICULAR PERFORATION 9 0.0044
53 NEPHROGENIC ANAEMIA 20 0.0043
54 PEPTIC ULCER HAEMORRHAGE 3 0.0043
55 TRANSIENT GLOBAL AMNESIA 3 0.0042
56 CLONIC CONVULSION 3 0.0041
57 AORTIC STENOSIS 14 0.0040
58 COLITIS ISCHAEMIC 27 0.0040
59 REBOUND ACID HYPERSECRETION 12 0.0040
60 SUBCUTANEOUS HAEMATOMA 5 0.0039
61 POSTICTAL STATE 4 0.0038
62 FAECAL VOLUME INCREASED 2 0.0038
63 OCCULT BLOOD 2 0.0038
64 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
65 BLOOD PHOSPHORUS INCREASED 10 0.0037
66 GASTROINTESTINAL TRACT IRRITATION 4 0.0037
67 DRUG EFFECT PROLONGED 2 0.0036
68 AORTIC DILATATION 4 0.0036
69 GASTRIC DILATATION 6 0.0036
70 PORTAL HYPERTENSIVE GASTROPATHY 2 0.0035
71 COMA SCALE ABNORMAL 10 0.0034
72 ILEUS 41 0.0033
73 BENIGN PROSTATIC HYPERPLASIA 17 0.0033
74 ADENOCARCINOMA GASTRIC 3 0.0032
75 GASTROINTESTINAL NECROSIS 9 0.0031
76 INTERNAL INJURY 2 0.0031
77 ASPIRATION 33 0.0030
78 PSYCHOTIC BEHAVIOUR 3 0.0030
79 FAECALOMA 16 0.0029
80 RETCHING 62 0.0029
81 ANASTOMOTIC LEAK 2 0.0029
82 OPHTHALMIC MIGRAINE 2 0.0029
83 FOREARM FRACTURE 2 0.0029
84 HYPOPHOSPHATAEMIA 21 0.0028
85 GASTROINTESTINAL SOUNDS ABNORMAL 14 0.0028
86 ENTEROCOLITIS HAEMORRHAGIC 4 0.0027
87 PARAESTHESIA ORAL 38 0.0026
88 REACTION TO EXCIPIENT 6 0.0026
89 ISCHAEMIC CEREBRAL INFARCTION 3 0.0026
90 PRODUCT DEPOSIT 4 0.0026
91 RECTAL ULCER 3 0.0026
92 PRODUCT USE COMPLAINT 40 0.0025
93 END STAGE RENAL DISEASE 46 0.0025
94 VENTRICULAR FIBRILLATION 28 0.0025
95 ALLERGIC REACTION TO EXCIPIENT 5 0.0025
96 EROSIVE DUODENITIS 2 0.0025
97 PERFORATION 2 0.0025
98 LARGE INTESTINE PERFORATION 17 0.0024
99 THERAPEUTIC PRODUCT EFFECT DELAYED 11 0.0024
100 HYPERNATRAEMIA 12 0.0024
101 MEAN PLATELET VOLUME DECREASED 2 0.0024
102 CONGENITAL CYSTIC KIDNEY DISEASE 2 0.0024
103 LEFT ATRIAL DILATATION 3 0.0024
104 MACULAR DEGENERATION 28 0.0023
105 HYPONATRAEMIA 130 0.0023
106 TUMOUR PAIN 3 0.0023
107 ABDOMINAL SEPSIS 2 0.0023
108 ANORECTAL DISCOMFORT 12 0.0023
109 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
110 MYASTHENIA GRAVIS 18 0.0022
111 IRON DEFICIENCY 10 0.0022
112 GASTRIC PERFORATION 6 0.0022
113 ANAL HAEMORRHAGE 6 0.0021
114 KLEBSIELLA BACTERAEMIA 2 0.0021
115 TROPONIN INCREASED 16 0.0021
116 DUODENAL ULCER HAEMORRHAGE 6 0.0021
117 CEREBELLAR ATAXIA 2 0.0021
118 ELECTROLYTE IMBALANCE 24 0.0021
119 OCCULT BLOOD POSITIVE 4 0.0020
120 PROCTALGIA 13 0.0020
121 CIRCULATORY COLLAPSE 34 0.0020
122 MYOCLONIC EPILEPSY 3 0.0020
123 PARKINSON'S DISEASE 5 0.0020
124 DYSCHEZIA 6 0.0020
125 CARDIAC MURMUR 17 0.0020
126 BLOOD PRESSURE IMMEASURABLE 3 0.0020
127 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 3 0.0020
128 RECTAL CANCER 6 0.0020
129 CHOLANGITIS SCLEROSING 4 0.0019
130 AORTIC ARTERIOSCLEROSIS 5 0.0019
131 OEDEMA MUCOSAL 2 0.0019
132 LUNG OPACITY 5 0.0019
133 INTESTINAL ULCER 3 0.0019
134 EXOPHTHALMOS 4 0.0019
135 PRESYNCOPE 45 0.0018
136 RESPIRATORY ALKALOSIS 3 0.0018
137 CARDIOVASCULAR INSUFFICIENCY 3 0.0018
138 BLOOD CALCIUM INCREASED 16 0.0018
139 MUCOUS STOOLS 9 0.0018
140 NEPHROSCLEROSIS 2 0.0018
141 PELVIC ABSCESS 2 0.0017
142 CARBON DIOXIDE DECREASED 2 0.0017
143 BLOOD URIC ACID INCREASED 10 0.0017
144 HYPOCHLORAEMIA 2 0.0017
145 HYPORESPONSIVE TO STIMULI 2 0.0017
146 COLD SWEAT 30 0.0017
147 GASTROINTESTINAL OEDEMA 3 0.0017
148 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
149 GASTROINTESTINAL MOTILITY DISORDER 9 0.0017
150 HYPERLIPIDAEMIA 20 0.0017
151 NASAL OEDEMA 3 0.0017
152 PNEUMOPERITONEUM 3 0.0016
153 INTESTINAL PERFORATION 18 0.0016
154 SMALL INTESTINAL PERFORATION 3 0.0016
155 TRAUMATIC HAEMORRHAGE 3 0.0016
156 PERIPHERAL SENSORIMOTOR NEUROPATHY 2 0.0016
157 HYPERAESTHESIA TEETH 2 0.0016
158 VAGINAL DISCHARGE 16 0.0016
159 SEDATION COMPLICATION 4 0.0016
160 GOUT 28 0.0016
161 HYPERCHOLESTEROLAEMIA 15 0.0016
162 SKIN EROSION 5 0.0016
163 FEELING COLD 43 0.0015
164 NON-HODGKIN'S LYMPHOMA 2 0.0015
165 ENCEPHALITIS AUTOIMMUNE 2 0.0015
166 NEAR DEATH EXPERIENCE 5 0.0015
167 ULCER 24 0.0015
168 ANORECTAL DISORDER 3 0.0015
169 HAEMATEMESIS 38 0.0015
170 CARDIAC DISCOMFORT 3 0.0015
171 LYMPHOCYTE PERCENTAGE DECREASED 2 0.0015
172 MICTURITION URGENCY 17 0.0015
173 FOAMING AT MOUTH 3 0.0015
174 ABDOMINAL RIGIDITY 4 0.0015
175 ISCHAEMIC HEPATITIS 2 0.0015
176 BRONCHOPNEUMONIA 5 0.0015
177 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 25 0.0015
178 REGURGITATION 5 0.0015
179 FUNCTIONAL GASTROINTESTINAL DISORDER 5 0.0014
180 PRODUCT PHYSICAL CONSISTENCY ISSUE 8 0.0014
181 ACIDOSIS 11 0.0014
182 ECHOCARDIOGRAM ABNORMAL 2 0.0014
183 BLOOD TEST ABNORMAL 20 0.0014
184 ANTIPSYCHOTIC DRUG LEVEL INCREASED 4 0.0014
185 BLOOD ELECTROLYTES DECREASED 2 0.0014
186 DEHYDRATION 187 0.0014
187 VITAMIN B12 DECREASED 4 0.0014
188 PERIPHERAL SENSORY NEUROPATHY 8 0.0014
189 ACUTE ABDOMEN 2 0.0014
190 GASTRITIS HAEMORRHAGIC 2 0.0013
191 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
192 GASTROINTESTINAL WALL THICKENING 2 0.0013
193 MENTAL FATIGUE 2 0.0013
194 ADHESION 2 0.0013
195 FULL BLOOD COUNT ABNORMAL 14 0.0013
196 DRUG EFFECT DELAYED 6 0.0013
197 ORAL PRURITUS 3 0.0013
198 ORAL MUCOSAL ERUPTION 2 0.0013
199 OESOPHAGEAL ULCER 5 0.0013
200 ALTERED STATE OF CONSCIOUSNESS 28 0.0013
201 ORAL CANDIDIASIS 17 0.0013
202 THIRST 23 0.0013
203 MEGACOLON 2 0.0013
204 INTESTINAL ISCHAEMIA 7 0.0013
205 PUSTULE 3 0.0013
206 VOMITING 593 0.0013
207 PHARYNGEAL PARAESTHESIA 2 0.0013
208 BLADDER PAIN 4 0.0013
209 FREQUENT BOWEL MOVEMENTS 34 0.0013
210 HYPOKALAEMIA 58 0.0013
211 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
212 FAECAL INCONTINENCE 6 0.0012
213 BACTERIAL INFECTION 23 0.0012
214 OROPHARYNGEAL BLISTERING 2 0.0012
215 ABNORMAL FAECES 10 0.0012
216 INTESTINAL POLYP 2 0.0012
217 SUFFOCATION FEELING 3 0.0012
218 HYPERVENTILATION 7 0.0012
219 RALES 7 0.0012
220 CYTOLYTIC HEPATITIS 4 0.0012
221 BILIARY DYSKINESIA 2 0.0012
222 APPENDICITIS 11 0.0012
223 ENTERITIS INFECTIOUS 2 0.0012
224 BLOOD CHLORIDE DECREASED 3 0.0012
225 BLOOD CHLORIDE INCREASED 2 0.0012
226 ABDOMINAL DISTENSION 120 0.0011
227 PSYCHOMOTOR SKILLS IMPAIRED 3 0.0011
228 CARDIOVASCULAR DISORDER 29 0.0011
229 EOSINOPHILIA 20 0.0011
230 AORTIC VALVE STENOSIS 2 0.0011
231 ANAL INCONTINENCE 10 0.0011
232 PNEUMOMEDIASTINUM 2 0.0011
233 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
234 GASTROINTESTINAL PAIN 12 0.0011
235 PNEUMONIA ASPIRATION 27 0.0011
236 ADRENAL DISORDER 2 0.0010
237 LOWER RESPIRATORY TRACT INFECTION 47 0.0010
238 FAECES HARD 4 0.0010
239 OESOPHAGEAL PAIN 4 0.0010
240 BRAIN HERNIATION 3 0.0010
241 OBSTRUCTIVE AIRWAYS DISORDER 11 0.0010
242 UROSEPSIS 9 0.0010
243 GRAND MAL CONVULSION 9 0.0010
244 CHANGE OF BOWEL HABIT 2 0.0010
245 AORTIC DISSECTION 4 0.0010
246 DIARRHOEA HAEMORRHAGIC 9 0.0010
247 CHILLS 112 0.0010
248 CYANOSIS 15 0.0010
249 HALLUCINATIONS, MIXED 4 0.0010
250 CHRONIC KIDNEY DISEASE 72 0.0009
251 FAECAL CALPROTECTIN INCREASED 3 0.0009
252 NEURALGIA 23 0.0009
253 AORTIC VALVE INCOMPETENCE 4 0.0009
254 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
255 ANURIA 8 0.0009
256 LANGUAGE DISORDER 2 0.0009
257 COLITIS 35 0.0009
258 STAPHYLOCOCCAL BACTERAEMIA 4 0.0009
259 PERITONITIS 19 0.0009
260 IMMOBILE 4 0.0009
261 RECTAL HAEMORRHAGE 39 0.0009
262 PROCEDURAL PAIN 25 0.0009
263 ILEUS PARALYTIC 4 0.0009
264 LARGE INTESTINAL OBSTRUCTION 2 0.0009
265 ACUTE PULMONARY OEDEMA 5 0.0009
266 FEAR OF DEATH 2 0.0009
267 CHRONIC GASTRITIS 2 0.0009
268 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 63 0.0009
269 PRODUCT LABEL ISSUE 6 0.0009
270 BLOOD LOSS ANAEMIA 2 0.0009
271 MULTIPLE ORGAN DYSFUNCTION SYNDROME 25 0.0009
272 INTESTINAL OBSTRUCTION 33 0.0009
273 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 45 0.0009
274 HYPOVOLAEMIA 5 0.0009
275 ANAPHYLACTIC SHOCK 22 0.0009
276 CARDIOGENIC SHOCK 12 0.0008
277 DIABETES INSIPIDUS 2 0.0008
278 GASTROINTESTINAL OBSTRUCTION 2 0.0008
279 SHOCK 19 0.0008
280 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
281 LOSS OF CONSCIOUSNESS 105 0.0008
282 PALLOR 22 0.0008
283 ABDOMINAL TENDERNESS 4 0.0008
284 PERSECUTORY DELUSION 2 0.0008
285 URINE OUTPUT DECREASED 7 0.0008
286 ABDOMINAL PAIN 185 0.0008
287 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
288 PHLEBITIS 4 0.0008
289 PHYSICAL DECONDITIONING 2 0.0008
290 ERUCTATION 15 0.0008
291 OPTIC ISCHAEMIC NEUROPATHY 3 0.0008
292 BLOOD PRESSURE DECREASED 51 0.0008
293 PERSONALITY DISORDER 2 0.0008
294 CEREBRAL ATROPHY 3 0.0008
295 OBSTRUCTION 3 0.0008
296 JOINT INJURY 16 0.0007
297 ORGAN FAILURE 3 0.0007
298 BRONCHIECTASIS 5 0.0007
299 ANAPHYLACTIC REACTION 41 0.0007
300 EAR CONGESTION 2 0.0007
301 LARGE INTESTINAL ULCER 2 0.0007
302 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
303 IMPAIRED GASTRIC EMPTYING 10 0.0007
304 PERIPHERAL COLDNESS 10 0.0007
305 MELAENA 16 0.0007
306 HAEMATOCHEZIA 40 0.0007
307 GASTROINTESTINAL PERFORATION 3 0.0007
308 PHARYNGEAL SWELLING 7 0.0007
309 DUODENAL ULCER 5 0.0007
310 RENAL FAILURE ACUTE 30 0.0007
311 PNEUMATOSIS INTESTINALIS 2 0.0007
312 HYPERTONIA 4 0.0007
313 METASTATIC NEOPLASM 3 0.0007
314 ENTEROCOLITIS 4 0.0007
315 ESCHERICHIA SEPSIS 2 0.0007
316 DIVERTICULUM INTESTINAL 3 0.0007
317 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
318 HAEMORRHOIDS 13 0.0007
319 HYPERCAPNIA 2 0.0007
320 CRANIOCEREBRAL INJURY 2 0.0007
321 BOWEL MOVEMENT IRREGULARITY 5 0.0007
322 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
323 DUODENITIS 2 0.0007
324 DIASTOLIC DYSFUNCTION 2 0.0006
325 MULTIPLE MYELOMA 3 0.0006
326 PERFORMANCE STATUS DECREASED 3 0.0006
327 BLOOD CREATININE DECREASED 2 0.0006
328 GASTROINTESTINAL INFLAMMATION 5 0.0006
329 FLATULENCE 36 0.0006
330 DELIRIUM 22 0.0006
331 BRAIN OEDEMA 8 0.0006
332 SPUTUM DISCOLOURED 6 0.0006
333 DEPRESSED LEVEL OF CONSCIOUSNESS 25 0.0006
334 BLOOD POTASSIUM DECREASED 19 0.0006
335 GENERAL PHYSICAL HEALTH DETERIORATION 73 0.0006
336 PULSE ABSENT 3 0.0006
337 TRANSAMINASES INCREASED 14 0.0006
338 HYPERTENSIVE CRISIS 7 0.0006
339 ATRIAL FLUTTER 5 0.0006
340 HYPOVOLAEMIC SHOCK 3 0.0006
341 SYNCOPE 62 0.0006
342 INCOHERENT 4 0.0006
343 OEDEMA MOUTH 2 0.0006
344 RENAL TUBULAR NECROSIS 6 0.0006
345 POLYP 4 0.0006
346 PRODUCT PREPARATION ISSUE 4 0.0006
347 SPRUE-LIKE ENTEROPATHY 3 0.0006
348 PRODUCT FORMULATION ISSUE 4 0.0006
349 COLITIS ULCERATIVE 27 0.0006
350 COLON CANCER 9 0.0006
351 SALIVARY HYPERSECRETION 6 0.0006
352 FLUID INTAKE REDUCED 3 0.0006
353 FAECES DISCOLOURED 13 0.0006
354 NEPHRITIS 2 0.0006
355 CORONARY ARTERY DISEASE 18 0.0006
356 NAUSEA 470 0.0006
357 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
358 MYOCLONUS 7 0.0006
359 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
360 NEUTROPHIL COUNT INCREASED 6 0.0006
361 PHARYNGEAL OEDEMA 9 0.0006
362 CACHEXIA 3 0.0006
363 CEREBRAL ISCHAEMIA 3 0.0006
364 ASCITES 17 0.0006
365 LARGE INTESTINE POLYP 4 0.0006
366 MEDICATION ERROR 32 0.0006
367 CATATONIA 3 0.0006
368 URINARY RETENTION 19 0.0006
369 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
370 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
371 GLOSSITIS 2 0.0006
372 TRANSIENT ISCHAEMIC ATTACK 19 0.0006
373 CONJUNCTIVAL HYPERAEMIA 2 0.0006
374 NEUTROPENIC SEPSIS 4 0.0006
375 FACIAL BONES FRACTURE 2 0.0006
376 BONE LESION 2 0.0006
377 TREMOR 92 0.0006
378 ABDOMINAL PAIN LOWER 14 0.0006
379 OROPHARYNGEAL DISCOMFORT 5 0.0006
380 MONOCYTE COUNT INCREASED 2 0.0006
381 LIQUID PRODUCT PHYSICAL ISSUE 4 0.0005
382 ORAL DISORDER 4 0.0005
383 SWOLLEN TONGUE 17 0.0005
384 RENAL FAILURE 71 0.0005
385 OCULAR DISCOMFORT 6 0.0005
386 OEDEMA PERIPHERAL 65 0.0005
387 PHOTOPHOBIA 10 0.0005
388 GENERALISED ERYTHEMA 3 0.0005
389 FACE INJURY 2 0.0005
390 PRODUCT PACKAGING ISSUE 5 0.0005
391 PULMONARY EMBOLISM 50 0.0005
392 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
393 SWELLING FACE 34 0.0005
394 GINGIVAL DISORDER 2 0.0005
395 OESOPHAGEAL DISORDER 2 0.0005
396 DIZZINESS POSTURAL 5 0.0005
397 PRODUCT LABEL CONFUSION 3 0.0005
398 LIVER FUNCTION TEST INCREASED 11 0.0005
399 SPLENOMEGALY 6 0.0005
400 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
401 GASTROOESOPHAGEAL REFLUX DISEASE 41 0.0005
402 BRADYCARDIA 27 0.0005
403 BODY TEMPERATURE DECREASED 5 0.0005
404 INABILITY TO AFFORD MEDICATION 5 0.0005
405 TRICUSPID VALVE INCOMPETENCE 4 0.0005
406 METABOLIC ACIDOSIS 16 0.0005
407 ANGIOEDEMA 22 0.0005
408 LIVER DISORDER 22 0.0005
409 ABDOMINAL PAIN UPPER 102 0.0005
410 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
411 SNEEZING 11 0.0005
412 SMALL INTESTINAL OBSTRUCTION 6 0.0005
413 EXTRAVASATION 2 0.0005
414 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
415 PIGMENTATION DISORDER 3 0.0005
416 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
417 FLUID OVERLOAD 7 0.0005
418 PRODUCT ODOUR ABNORMAL 5 0.0005
419 NASAL CONGESTION 28 0.0005
420 FACE OEDEMA 8 0.0005
421 HYPERPYREXIA 2 0.0005
422 CONSTIPATION 103 0.0005
423 WHEEZING 28 0.0005
424 RENAL PAIN 5 0.0005
425 SCREAMING 3 0.0005
426 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
427 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
428 LUNG NEOPLASM 2 0.0005
429 HAEMOGLOBIN ABNORMAL 3 0.0005
430 HAEMOPTYSIS 13 0.0005
431 ABNORMAL SENSATION IN EYE 2 0.0005
432 HYPOAESTHESIA ORAL 7 0.0005
433 BLOOD MAGNESIUM DECREASED 4 0.0005
434 ORTHOSTATIC HYPOTENSION 8 0.0005
435 OESOPHAGITIS 5 0.0005
436 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
437 SLEEP DISORDER 32 0.0005
438 ABDOMINAL ABSCESS 2 0.0005
439 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
440 URTICARIA 75 0.0004
441 DYSPEPSIA 44 0.0004
442 ILL-DEFINED DISORDER 27 0.0004
443 WHITE BLOOD CELL COUNT INCREASED 17 0.0004
444 HAEMOGLOBIN INCREASED 2 0.0004
445 EYE MOVEMENT DISORDER 3 0.0004
446 RENAL INJURY 13 0.0004
447 LUMBAR VERTEBRAL FRACTURE 2 0.0004
448 ISCHAEMIA 2 0.0004
449 IRON DEFICIENCY ANAEMIA 4 0.0004
450 DIVERTICULITIS 12 0.0004
451 DRY MOUTH 35 0.0004
452 ACUTE KIDNEY INJURY 66 0.0004
453 EXTRASYSTOLES 3 0.0004
454 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
455 DEFAECATION URGENCY 3 0.0004
456 SWELLING 40 0.0004
457 DISCOMFORT 26 0.0004
458 BLOOD SODIUM DECREASED 8 0.0004
459 AGITATION 31 0.0004
460 PROTEINURIA 8 0.0004
461 BLOOD PRESSURE INCREASED 64 0.0004
462 NON-SMALL CELL LUNG CANCER 2 0.0004
463 IMPAIRED QUALITY OF LIFE 6 0.0004
464 ASTHMA 47 0.0004
465 SINUS BRADYCARDIA 4 0.0004
466 BLOOD CREATININE INCREASED 27 0.0004
467 HAEMORRHOIDAL HAEMORRHAGE 2 0.0004
468 THROAT TIGHTNESS 11 0.0004
469 URINARY INCONTINENCE 12 0.0004
470 ABNORMAL BEHAVIOUR 16 0.0004
471 DISORIENTATION 16 0.0004
472 ANEURYSM 2 0.0004
473 HYPOTONIA 4 0.0004
474 HYPERAMMONAEMIA 2 0.0004
475 PRODUCTIVE COUGH 19 0.0004
476 ERYTHEMA 81 0.0004
477 SUBARACHNOID HAEMORRHAGE 4 0.0004
478 AMMONIA INCREASED 2 0.0004
479 PETIT MAL EPILEPSY 2 0.0004
480 ATRIAL FIBRILLATION 38 0.0004
481 FEMORAL NECK FRACTURE 2 0.0004
482 ENDOCARDITIS 2 0.0004
483 INCREASED UPPER AIRWAY SECRETION 2 0.0004
484 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
485 PERIPHERAL VASCULAR DISORDER 2 0.0004
486 ATRIOVENTRICULAR BLOCK 3 0.0004
487 CONCUSSION 3 0.0004
488 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
489 HIATUS HERNIA 5 0.0004
490 EJECTION FRACTION DECREASED 6 0.0004
491 DRUG EFFECT INCOMPLETE 14 0.0004
492 APNOEA 3 0.0004
493 TENDERNESS 4 0.0004
494 CONFUSIONAL STATE 62 0.0004
495 DRUG INTOLERANCE 37 0.0004
496 APLASTIC ANAEMIA 2 0.0004
497 TACHYCARDIA 34 0.0004
498 ELECTROCARDIOGRAM ABNORMAL 3 0.0004
499 PYREXIA 132 0.0004
500 INCONTINENCE 4 0.0004
501 RENAL CYST 3 0.0004
502 ANAEMIA 72 0.0004
503 PRURITUS GENERALISED 8 0.0004
504 HYPOXIA 13 0.0004
505 SHOCK HAEMORRHAGIC 3 0.0004
506 HICCUPS 3 0.0004
507 WOUND INFECTION 4 0.0004
508 APHASIA 11 0.0004
509 DYSGEUSIA 27 0.0004
510 RESPIRATORY ARREST 10 0.0004
511 CHOKING SENSATION 2 0.0004
512 MALAISE 159 0.0004
513 LIP SWELLING 12 0.0004
514 ON AND OFF PHENOMENON 2 0.0004
515 HYPOMAGNESAEMIA 5 0.0004
516 ASTHENIA 135 0.0004
517 INTRACRANIAL PRESSURE INCREASED 2 0.0004
518 DISSEMINATED INTRAVASCULAR COAGULATION 5 0.0004
519 COLECTOMY 2 0.0004
520 MYOCARDIAL ISCHAEMIA 4 0.0004
521 NEUROLOGICAL SYMPTOM 2 0.0003
522 UNRESPONSIVE TO STIMULI 9 0.0003
523 PARANOIA 6 0.0003
524 PSYCHOLOGICAL TRAUMA 3 0.0003
525 HAEMATOMA 9 0.0003
526 MYOPATHY 3 0.0003
527 MOUTH SWELLING 2 0.0003
528 PLEURAL EFFUSION 21 0.0003
529 HYPERSENSITIVITY 64 0.0003
530 SEPTIC SHOCK 15 0.0003
531 EYELID OEDEMA 4 0.0003
532 HYPERKALAEMIA 12 0.0003
533 BRADYKINESIA 2 0.0003
534 DRUG ERUPTION 6 0.0003
535 SEIZURE 39 0.0003
536 OCULAR HYPERAEMIA 16 0.0003
537 DIARRHOEA 217 0.0003
538 CHOLECYSTITIS 4 0.0003
539 PULMONARY MASS 5 0.0003
540 HEARING IMPAIRED 2 0.0003
541 SKIN DISORDER 11 0.0003
542 CEREBRAL INFARCTION 8 0.0003
543 CARDIAC ARREST 27 0.0003
544 LUNG DISORDER 16 0.0003
545 LARYNGEAL OEDEMA 2 0.0003
546 PALPITATIONS 38 0.0003
547 THROMBOSIS 26 0.0003
548 PERSONALITY CHANGE 3 0.0003
549 SOMNOLENCE 65 0.0003
550 NASAL DRYNESS 2 0.0003
551 HYPOCALCAEMIA 6 0.0003
552 PHOTOPSIA 2 0.0003
553 BLOOD URINE PRESENT 6 0.0003
554 HEPATOTOXICITY 7 0.0003
555 ANGINA PECTORIS 9 0.0003
556 SEPSIS 35 0.0003
557 PULMONARY FIBROSIS 6 0.0003
558 CARDIO-RESPIRATORY ARREST 13 0.0003
559 MUSCLE SPASMS 57 0.0003
560 HYPERHIDROSIS 40 0.0003
561 ABDOMINAL DISCOMFORT 52 0.0003
562 INTENTIONAL PRODUCT MISUSE 27 0.0003
563 PARKINSONISM 3 0.0003
564 ACUTE MYOCARDIAL INFARCTION 9 0.0003
565 METASTASES TO BONE 5 0.0003
566 NECK PAIN 17 0.0003
567 HYPERTENSION 64 0.0003
568 COGNITIVE DISORDER 14 0.0003
569 AGGRESSION 15 0.0003
570 BRAIN INJURY 3 0.0003
571 METASTASES TO LYMPH NODES 2 0.0003
572 POSTOPERATIVE WOUND INFECTION 2 0.0003
573 RASH PRURITIC 16 0.0003
574 DRY THROAT 3 0.0003
575 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
576 DIZZINESS 147 0.0003
577 EPILEPSY 9 0.0003
578 TACHYPNOEA 4 0.0003
579 BODY TEMPERATURE INCREASED 6 0.0003
580 DRUG ADMINISTRATION ERROR 9 0.0003
581 EAR DISCOMFORT 3 0.0003
582 GASTROINTESTINAL DISORDER 26 0.0003
583 HYPERBILIRUBINAEMIA 3 0.0003
584 DIABETES MELLITUS 22 0.0003
585 HEADACHE 180 0.0003
586 WEIGHT FLUCTUATION 3 0.0003
587 INFUSION RELATED REACTION 19 0.0003
588 DYSPHAGIA 27 0.0003
589 PAPULE 2 0.0003
590 HEAD DISCOMFORT 5 0.0003
591 ASPARTATE AMINOTRANSFERASE INCREASED 15 0.0003
592 HAND FRACTURE 2 0.0003
593 DIALYSIS 4 0.0003
594 IMPAIRED WORK ABILITY 6 0.0003
595 AGEUSIA 7 0.0003
596 IRRITABLE BOWEL SYNDROME 6 0.0003
597 CONVULSION 16 0.0003
598 RHINORRHOEA 18 0.0003
599 GASTROINTESTINAL HAEMORRHAGE 23 0.0003
600 FAECES SOFT 2 0.0003
601 HYPERGLYCAEMIA 10 0.0003
602 GASTROENTERITIS 4 0.0003
603 BLINDNESS TRANSIENT 2 0.0003
604 SKIN ULCER 7 0.0003
605 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
606 RASH GENERALISED 7 0.0003
607 NEUTROPHIL COUNT DECREASED 11 0.0003
608 WEIGHT DECREASED 75 0.0003
609 HEPATIC STEATOSIS 5 0.0003
610 HYDRONEPHROSIS 2 0.0003
611 FEELING ABNORMAL 64 0.0003
612 CHROMATURIA 6 0.0003
613 PAROSMIA 2 0.0003
614 ECONOMIC PROBLEM 4 0.0003
615 INTERNAL HAEMORRHAGE 3 0.0003
616 MUSCULOSKELETAL STIFFNESS 23 0.0003
617 VERTIGO 16 0.0003
618 HYPERTHERMIA 2 0.0003
619 PROCEDURAL COMPLICATION 2 0.0003
620 CHOLESTASIS 5 0.0003
621 HAEMOLYSIS 2 0.0003
622 NEOPLASM PROGRESSION 9 0.0003
623 MUSCULOSKELETAL CHEST PAIN 4 0.0003
624 DRUG INTERACTION 41 0.0003
625 POST PROCEDURAL HAEMORRHAGE 3 0.0003
626 LUNG INFECTION 4 0.0003
627 HAEMORRHAGIC STROKE 2 0.0003
628 BLOOD IRON DECREASED 3 0.0003
629 HEAD INJURY 8 0.0003
630 NASAL DISCOMFORT 2 0.0003
631 BLOOD ALBUMIN DECREASED 2 0.0003
632 MIOSIS 2 0.0002
633 EYE PAIN 14 0.0002
634 SPEECH DISORDER 13 0.0002
635 HYPOGLYCAEMIA 12 0.0002
636 ADRENAL INSUFFICIENCY 3 0.0002
637 NOCTURIA 3 0.0002
638 SCHIZOPHRENIA 3 0.0002
639 PULMONARY OEDEMA 11 0.0002
640 DYSPNOEA 139 0.0002
641 DECUBITUS ULCER 2 0.0002
642 ASPHYXIA 2 0.0002
643 CARDIOMEGALY 3 0.0002
644 PRODUCT PREPARATION ERROR 5 0.0002
645 RIB FRACTURE 5 0.0002
646 GENERALISED OEDEMA 3 0.0002
647 EYE SWELLING 9 0.0002
648 ACUTE CORONARY SYNDROME 2 0.0002
649 MIGRAINE 23 0.0002
650 HEMIPLEGIA 2 0.0002
651 PULMONARY HYPERTENSION 5 0.0002
652 HYPOTENSION 48 0.0002
653 BLOOD UREA INCREASED 4 0.0002
654 DERMATITIS ALLERGIC 3 0.0002
655 HAEMOGLOBIN DECREASED 24 0.0002
656 ILLNESS 24 0.0002
657 PANCYTOPENIA 13 0.0002
658 HEART RATE INCREASED 23 0.0002
659 FALL 77 0.0002
660 OXYGEN SATURATION DECREASED 13 0.0002
661 STOMATITIS 14 0.0002
662 DEEP VEIN THROMBOSIS 15 0.0002
663 PLATELET COUNT INCREASED 3 0.0002
664 RASH MACULAR 8 0.0002
665 FEELING HOT 14 0.0002
666 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
667 GAMMA-GLUTAMYLTRANSFERASE INCREASED 5 0.0002
668 UNEVALUABLE EVENT 17 0.0002
669 CARDIAC FAILURE 18 0.0002
670 FACIAL PAIN 2 0.0002
671 FEAR 6 0.0002
672 JAUNDICE 6 0.0002
673 THROAT IRRITATION 10 0.0002
674 DISTURBANCE IN ATTENTION 12 0.0002
675 HEART RATE IRREGULAR 5 0.0002
676 LEUKOCYTOSIS 4 0.0002
677 GASTROINTESTINAL CARCINOMA 2 0.0002
678 OPTIC NEURITIS 2 0.0002
679 C-REACTIVE PROTEIN INCREASED 8 0.0002
680 GINGIVAL BLEEDING 3 0.0002
681 INCREASED TENDENCY TO BRUISE 2 0.0002
682 ORAL DISCOMFORT 3 0.0002
683 RHABDOMYOLYSIS 9 0.0002
684 DECREASED APPETITE 50 0.0002
685 BLOOD CHOLESTEROL INCREASED 10 0.0002
686 NEPHROPATHY 2 0.0002
687 ARRHYTHMIA 10 0.0002
688 GASTRIC ULCER 4 0.0002
689 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 2 0.0002
690 MOBILITY DECREASED 15 0.0002
691 SEROTONIN SYNDROME 4 0.0002
692 LIVER FUNCTION TEST ABNORMAL 6 0.0002
693 MENTAL IMPAIRMENT 5 0.0002
694 DYSTONIA 4 0.0002
695 EAR PAIN 4 0.0002
696 THROMBOCYTOPENIA 23 0.0002
697 DRUG INEFFECTIVE 271 0.0002
698 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
699 CHOKING 4 0.0002
700 INFLAMMATORY BOWEL DISEASE 2 0.0002
701 COELIAC DISEASE 2 0.0002
702 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
703 OSTEONECROSIS OF JAW 5 0.0002
704 BLADDER DISORDER 2 0.0002
705 PERIPHERAL SWELLING 31 0.0002
706 HAEMORRHAGE 21 0.0002
707 RESPIRATORY DISORDER 6 0.0002
708 EPISTAXIS 15 0.0002
709 THERAPEUTIC RESPONSE DECREASED 12 0.0002
710 PRODUCT ADMINISTRATION ERROR 4 0.0002
711 BLOOD COUNT ABNORMAL 3 0.0002
712 HYPOTHERMIA 2 0.0002
713 FEEDING DISORDER 4 0.0002
714 EYELID PTOSIS 2 0.0002
715 FLUID RETENTION 10 0.0002
716 MOTOR DYSFUNCTION 2 0.0002
717 FEBRILE NEUTROPENIA 13 0.0002
718 CEREBRAL HAEMORRHAGE 7 0.0002
719 WHITE BLOOD CELL COUNT DECREASED 21 0.0002
720 PNEUMONIA 62 0.0002
721 RESTLESSNESS 7 0.0002
722 NEUTROPENIA 26 0.0002
723 FOLLICULITIS 2 0.0002
724 ANHEDONIA 5 0.0002
725 DYSURIA 7 0.0002
726 GASTRITIS 5 0.0002
727 COMA 9 0.0002
728 RESPIRATORY TRACT CONGESTION 3 0.0002
729 HALLUCINATION, AUDITORY 3 0.0002
730 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
731 PRURITUS 72 0.0002
732 POOR QUALITY SLEEP 4 0.0002
733 PAIN 114 0.0002
734 DECREASED ACTIVITY 2 0.0002
735 LACTIC ACIDOSIS 6 0.0002
736 MUSCULAR WEAKNESS 21 0.0002
737 BLOOD POTASSIUM INCREASED 3 0.0002
738 INCORRECT PRODUCT ADMINISTRATION DURATION 4 0.0002
739 LIMB INJURY 5 0.0002
740 BLOOD GLUCOSE FLUCTUATION 2 0.0002
741 EYE DISORDER 6 0.0002
742 URINARY TRACT INFECTION 31 0.0002
743 VENTRICULAR TACHYCARDIA 3 0.0002
744 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
745 DRUG LEVEL INCREASED 3 0.0002
746 RESPIRATORY DISTRESS 5 0.0002
747 DENTAL CARIES 2 0.0002
748 COAGULOPATHY 3 0.0002
749 RASH MACULO-PAPULAR 4 0.0002
750 INCORRECT DOSE ADMINISTERED 41 0.0002
751 ORAL PAIN 4 0.0002
752 UPPER GASTROINTESTINAL HAEMORRHAGE 3 0.0002
753 BLOOD CALCIUM DECREASED 2 0.0002
754 MITRAL VALVE INCOMPETENCE 2 0.0002
755 IMPAIRED DRIVING ABILITY 2 0.0002
756 HAEMATURIA 6 0.0002
757 GASTRIC HAEMORRHAGE 2 0.0002
758 MULTI-ORGAN FAILURE 3 0.0002
759 METASTASES TO LUNG 2 0.0002
760 BACK PAIN 40 0.0002
761 CAESAREAN SECTION 2 0.0002
762 BURNING SENSATION 12 0.0002
763 METASTASES TO LIVER 3 0.0002
764 DEPRESSED MOOD 9 0.0002
765 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
766 PRODUCT PRESCRIBING ERROR 4 0.0002
767 POLLAKIURIA 7 0.0002
768 MUSCLE RIGIDITY 2 0.0002
769 FLUSHING 17 0.0002
770 CONTUSION 16 0.0002
771 FATIGUE 129 0.0002
772 LACRIMATION INCREASED 5 0.0002
773 PARAESTHESIA 26 0.0002
774 RESTLESS LEGS SYNDROME 3 0.0002
775 NEOPLASM MALIGNANT 11 0.0002
776 RESPIRATORY FAILURE 12 0.0002
777 MUSCLE SPASTICITY 2 0.0002
778 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
779 ABASIA 4 0.0002
780 CONJUNCTIVITIS 3 0.0002
781 PHARYNGITIS 2 0.0002
782 HEPATIC FUNCTION ABNORMAL 6 0.0002
783 DYSARTHRIA 6 0.0002
784 CELLULITIS 8 0.0002
785 CONDITION AGGRAVATED 48 0.0002
786 MUSCLE ATROPHY 2 0.0002
787 HYPOPHAGIA 4 0.0002
788 LETHARGY 9 0.0002
789 CHEST DISCOMFORT 16 0.0002
790 POST PROCEDURAL COMPLICATION 3 0.0002
791 MOVEMENT DISORDER 5 0.0002
792 RENAL IMPAIRMENT 13 0.0002
793 DIPLOPIA 4 0.0002
794 ORAL HERPES 3 0.0002
795 HYPOAESTHESIA 23 0.0002
796 ECZEMA 8 0.0002
797 NEPHROLITHIASIS 7 0.0002
798 CHOLELITHIASIS 5 0.0002
799 STAPHYLOCOCCAL INFECTION 5 0.0002
800 OROPHARYNGEAL PAIN 14 0.0002
801 BALANCE DISORDER 13 0.0002
802 EYE HAEMORRHAGE 2 0.0001
803 HOSPITALISATION 23 0.0001
804 CYTOKINE RELEASE SYNDROME 3 0.0001
805 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
806 HOT FLUSH 11 0.0001
807 GASTRIC DISORDER 5 0.0001
808 HUNGER 2 0.0001
809 COORDINATION ABNORMAL 2 0.0001
810 DEMENTIA 4 0.0001
811 MASS 2 0.0001
812 INSOMNIA 38 0.0001
813 INJURY 10 0.0001
814 HALLUCINATION, VISUAL 3 0.0001
815 OSTEOARTHRITIS 6 0.0001
816 ANXIETY 40 0.0001
817 BRONCHOSPASM 2 0.0001
818 HYPERSOMNIA 4 0.0001
819 ANOSMIA 2 0.0001
820 HYPERTHYROIDISM 2 0.0001
821 MENTAL DISORDER 6 0.0001
822 INJECTION SITE HAEMATOMA 2 0.0001
823 PANIC ATTACK 5 0.0001
824 DYSSTASIA 4 0.0001
825 DYSPHONIA 8 0.0001
826 GAIT DISTURBANCE 26 0.0001
827 PSYCHOTIC DISORDER 4 0.0001
828 RASH 59 0.0001
829 MUSCULOSKELETAL PAIN 7 0.0001
830 PANCREATITIS ACUTE 3 0.0001
831 HEPATIC FAILURE 4 0.0001
832 SKIN IRRITATION 6 0.0001
833 DRUG DISPENSING ERROR 2 0.0001
834 INSURANCE ISSUE 2 0.0001
835 TINNITUS 6 0.0001
836 MUSCLE TWITCHING 3 0.0001
837 PERICARDIAL EFFUSION 3 0.0001
838 FEMUR FRACTURE 4 0.0001
839 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
840 BASAL CELL CARCINOMA 2 0.0001
841 NERVOUS SYSTEM DISORDER 4 0.0001
842 TREATMENT NONCOMPLIANCE 7 0.0001
843 BRAIN FOG 2 0.0001
844 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
845 PNEUMOTHORAX 2 0.0001
846 PAIN IN EXTREMITY 37 0.0001
847 RASH ERYTHEMATOUS 6 0.0001
848 ABSCESS 2 0.0001
849 HYPOTHYROIDISM 4 0.0001
850 DIABETIC KETOACIDOSIS 3 0.0001
851 JOINT SWELLING 15 0.0001
852 CHEST PAIN 23 0.0001
853 MUSCLE TIGHTNESS 2 0.0001
854 DYSKINESIA 5 0.0001
855 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 22 0.0001
856 IMPAIRED HEALING 4 0.0001
857 MULTIPLE FRACTURES 2 0.0001
858 MANIA 2 0.0001
859 INFLUENZA LIKE ILLNESS 10 0.0001
860 PRODUCT USE IN UNAPPROVED INDICATION 30 0.0001
861 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
862 EXPIRED PRODUCT ADMINISTERED 4 0.0001
863 BONE PAIN 7 0.0001
864 PERICARDITIS 2 0.0001
865 HEMIPARESIS 2 0.0001
866 MYALGIA 20 0.0001
867 INFLAMMATION 6 0.0001
868 EMOTIONAL DISTRESS 14 0.0001
869 RESPIRATORY TRACT INFECTION 3 0.0001
870 DEAFNESS 3 0.0001
871 LOCAL SWELLING 2 0.0001
872 LYMPHOCYTE COUNT DECREASED 2 0.0001
873 LYMPHADENOPATHY 4 0.0001
874 EAR INFECTION 3 0.0001
875 DRY SKIN 15 0.0001
876 GALLBLADDER DISORDER 2 0.0001
877 BLOOD BILIRUBIN INCREASED 3 0.0001
878 GASTROENTERITIS VIRAL 2 0.0001
879 SKIN DISCOLOURATION 5 0.0001
880 BLOOD GLUCOSE ABNORMAL 2 0.0001
881 CARDIAC DISORDER 10 0.0001
882 BLISTER 6 0.0001
883 INCORRECT DRUG ADMINISTRATION DURATION 3 0.0001
884 OVERDOSE 23 0.0001
885 TARDIVE DYSKINESIA 3 0.0001
886 PAIN IN JAW 3 0.0001
887 RED BLOOD CELL COUNT DECREASED 3 0.0001
888 HERPES ZOSTER 6 0.0001
889 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 5 0.0001
890 OFF LABEL USE 91 0.0001
891 COUGH 29 0.0001
892 PRODUCT QUALITY ISSUE 14 0.0001
893 CATARACT 6 0.0001
894 LIMB DISCOMFORT 3 0.0001
895 ARTHRALGIA 40 0.0001
896 UNDERDOSE 7 0.0001
897 DERMATITIS 2 0.0001
898 KNEE ARTHROPLASTY 2 0.0001
899 PANCREATITIS 5 0.0001
900 BRONCHITIS 7 0.0001
901 HALLUCINATION 7 0.0001
902 AMNESIA 6 0.0001
903 OEDEMA 5 0.0001
904 PRODUCT DOSE OMISSION ISSUE 27 0.0001
905 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
906 BLOOD GLUCOSE INCREASED 17 0.0001
907 GAIT INABILITY 3 0.0001
908 GLOSSODYNIA 2 0.0001
909 THERAPEUTIC PRODUCT EFFECT DECREASED 4 0.0001
910 EYE PRURITUS 3 0.0001
911 ADVERSE DRUG REACTION 8 0.0001
912 MYOCARDIAL INFARCTION 15 0.0001
913 RENAL DISORDER 4 0.0001
914 HEART RATE DECREASED 3 0.0001
915 NEUROPATHY PERIPHERAL 8 0.0001
916 BLOOD PRESSURE FLUCTUATION 2 0.0001
917 INFECTION 12 0.0001
918 FIBROMYALGIA 2 0.0001
919 LIVER INJURY 2 0.0001
920 ENCEPHALOPATHY 2 0.0001
921 VISUAL IMPAIRMENT 10 0.0001
922 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
923 PRODUCT USE ISSUE 15 0.0001
924 GASTRIC CANCER 2 0.0001
925 SINUSITIS 8 0.0001
926 PHARMACEUTICAL PRODUCT COMPLAINT 2 0.0001
927 CEREBROVASCULAR ACCIDENT 13 0.0001
928 PRODUCT DOSE OMISSION 5 0.0001
929 MUCOSAL INFLAMMATION 2 0.0001
930 DRUG EFFECT DECREASED 4 0.0001
931 EXTRA DOSE ADMINISTERED 3 0.0001
932 PSORIATIC ARTHROPATHY 3 0.0001
933 LUNG NEOPLASM MALIGNANT 3 0.0001
934 MENTAL STATUS CHANGES 2 0.0001
935 INTENTIONAL DOSE OMISSION 2 0.0001
936 EYE IRRITATION 4 0.0001
937 SUICIDE ATTEMPT 4 0.0001
938 SUICIDAL IDEATION 6 0.0001
939 BONE DENSITY DECREASED 2 0.0001
940 ARTHRITIS 5 0.0001
941 MULTIPLE SCLEROSIS 3 0.0001
942 WEIGHT INCREASED 14 0.0001
943 CARDIAC FAILURE CONGESTIVE 5 0.0001
944 NIGHT SWEATS 2 0.0001
945 INTERSTITIAL LUNG DISEASE 3 0.0001
946 FUNGAL INFECTION 2 0.0001
947 LEUKOPENIA 3 0.0001
948 NASOPHARYNGITIS 11 0.0001
949 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 12 0.0001
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
951 HEPATIC ENZYME INCREASED 4 0.0001
952 THERAPY CESSATION 3 0.0001
953 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
954 VISION BLURRED 8 0.0001
955 NERVOUSNESS 3 0.0001
956 COVID-19 10 0.0001
957 THERAPY INTERRUPTED 4 0.0001
958 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
959 SKIN BURNING SENSATION 4 0.0001
960 DEATH 48 0.0001
961 ADVERSE EVENT 5 0.0001
962 DYSPNOEA EXERTIONAL 2 0.0001
963 RHEUMATOID ARTHRITIS 6 0.0001
964 SURGERY 3 0.0001
965 INJECTION SITE HAEMORRHAGE 4 0.0001
966 ABORTION SPONTANEOUS 2 0.0000
967 OSTEOPOROSIS 2 0.0000
968 ACCIDENTAL EXPOSURE TO PRODUCT 5 0.0000
969 DEPRESSION 11 0.0000
970 EXPOSURE DURING PREGNANCY 3 0.0000
971 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
972 INFLUENZA 5 0.0000
973 DISEASE PROGRESSION 5 0.0000
974 DISEASE RECURRENCE 2 0.0000
975 TOXICITY TO VARIOUS AGENTS 7 0.0000
976 DRY EYE 2 0.0000
977 ACNE 3 0.0000
978 NO ADVERSE EVENT 7 0.0000
979 PLATELET COUNT DECREASED 4 0.0000
980 PROSTATE CANCER 3 0.0000
981 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
982 IRRITABILITY 2 0.0000
983 DRUG DOSE OMISSION 5 0.0000
984 MEMORY IMPAIRMENT 4 0.0000
985 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
986 ALOPECIA 5 0.0000
987 INJECTION SITE BRUISING 2 0.0000
988 PSORIASIS 3 0.0000
989 DEVICE ISSUE 2 0.0000
990 INJECTION SITE ERYTHEMA 2 0.0000
991 INJECTION SITE PAIN 4 0.0000
992 DRUG DEPENDENCE 2 0.0000